5 years of experience implementing a methicillin-resistant staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands

Infection Control and Hospital Epidemiology

Volumn 30, Issue 10, 2009, Pages 977-984

  Vos, Margreet C ^a   Behrendt, Myra D ^a   Melles, Damian C ^a   Mollema, Femke P N ^a   De Groot, Woutrinus ^a   Parlevliet, Gerard ^a   Ott, Alewijn ^a   Horst Kreft, Deborah ^a   Van Belkum, Alex ^a   Verbrugh, Henri A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM CARRIER; BACTERIUM CULTURE; COMMUNICABLE DISEASE; DISINFECTION; HEALTH CARE POLICY; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NETHERLANDS; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT CARE;

ACADEMIC MEDICAL CENTERS; CARRIER STATE; CROSS INFECTION; CULTURE MEDIA; DISEASE OUTBREAKS; HEALTH PERSONNEL; HEALTH POLICY; HUMANS; INFECTION CONTROL; MASS SCREENING; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; NETHERLANDS; PATIENT ISOLATION; PROGRAM EVALUATION; STAPHYLOCOCCAL INFECTIONS;

EID: 70350037754     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/605921     Document Type: Article

References (21)

1. Tiemersma EW, Bronzwaer SL, Lyytikainen O, et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004; 10: 1627-1634.
2. Dutch Working Party on Infection Prevention (WIP). Policy for methicillin- restistant Staphylococcus aureus, 2003. Available at: http://www.wip.nl. Accessed January 2000.
3. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365:579-587.
4. Wertheim H, Verbrugh HA, van Pelt C, de Man P, van Belkum A, Vos MC. Improved detection of methicillin-resistant Staphylococcus aureus using phenyl mannitol broth containing aztreonam and ceftizoxime. J Clin Microbiol 2001; 39:2660-2662.
5. Kerremans JJ, Maaskant J, Verbrugh HA, van Leeuwen WB, Vos MC. Detection of methicillin-resistant Staphylococcus aureus in a low-prevalence setting by polymerase chain reaction with a selective enrichment broth. Diagn Microbiol Infect Dis 2008; 61:396-401.
6. van Trijp MJCA, Melles DC, Hendriks WDH, Parlevliet GA, Gommans M, Ott A. Successful control of widespread methicillin-resistant Staphylococcus aureus colonization and infection in a large teaching hospital in the Netherlands. Infect Control Hosp Epidemiol 2007; 28:970-975.
7. Vriens M, Blok H, Fluit A, Troelstra A, van Der Werken C, Verhoef J. Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey. Eur J Clin Microbiol Infect Dis 2002; 21:782-786.
8. Wertheim HF, Vos MC, Boelens HA, et al. Low prevalence of methicillinresistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect 2004; 56:321-325.
9. Jernigan JA, Titus MG, Groschel DH, Getchell-White S, Farr BM. Effectiveness of contact isolation during a hospital outbreak of methicillinresistant Staphylococcus aureus. Am J Epidemiol 1996; 143:496-504.
10. Bootsma MC, Diekmann O, Bonten MJ. Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing. Proc Natl Acad Sci U S A 2006; 103:5620-5625.
11. Salgado CD, Farr BM. What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiological cultures? Infect Control Hosp Epidemiol 2006; 27:116-121.
12. Lucet JC, Grenet K, Armand-Lefevre L, et al. High prevalence of carriage of methicillin-resistant Staphylococcus aureus at hospital admission in elderly patients: implications for infection control strategies. Infect Control Hosp Epidemiol 2005; 26:121-126.
13. Girou E, Azar J, Wolkenstein P, Cizeau F, Brun-Buisson C, Roujeau JC. Comparison of systematic versus selective screening for methicillin-resistant Staphylococcus aureus carriage in a high-risk dermatology ward. Infect Control Hosp Epidemiol 2000; 21:583-587.
14. Harbarth S, Masuet-Aumatell C, Schrenzel J, et al. Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care 2006; 10:R25.
15. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001; 344: 11-16. (Pubitemid 32064839)
16. Kluytmans JA, Mouton JW, Ijzerman EP, et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 1995; 171:216-219.
17. The European Antimicrobial Resistance Surveillance System (EARSS). Annual Report 2004. Available at: http://www.earss.rivm.nl. Accessed November 2008.
18. Harbarth S, Fankhauser C, Schrenzel J, et al. Universal screening for methicillin- resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008; 299:1149-1157.
19. Robicsek A, Beaumont JL, Paule SM, et al. Universal surveillance for methicillin- resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008; 148:409-418.
20. Salgado CD, Vos MC, Farr BM. Universal screening for methicillin resistant Staphylococcus aureus by hospitals. JAMA 2008; 300:503-504.
21. Vos MC, Ott A, Verbrugh HA. Successful search-and-destroy policy for methicillin-resistant Staphylococcus aureus in the Netherlands. J Clin Microbiol 2005; 43:2034-2035.